SCHIEPATTI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 2.112
AS - Asia 1.692
EU - Europa 1.305
SA - Sud America 251
AF - Africa 60
OC - Oceania 9
Totale 5.429
Nazione #
US - Stati Uniti d'America 2.060
CN - Cina 583
SG - Singapore 460
IE - Irlanda 273
IT - Italia 241
VN - Vietnam 212
RU - Federazione Russa 200
HK - Hong Kong 197
DE - Germania 167
BR - Brasile 165
FR - Francia 98
FI - Finlandia 90
GB - Regno Unito 75
IN - India 73
AR - Argentina 32
CA - Canada 32
BD - Bangladesh 29
ZA - Sudafrica 29
JP - Giappone 28
PT - Portogallo 24
EC - Ecuador 20
TR - Turchia 20
SE - Svezia 19
PL - Polonia 17
IQ - Iraq 16
BE - Belgio 14
ES - Italia 14
LT - Lituania 13
NL - Olanda 13
AT - Austria 12
MA - Marocco 12
CO - Colombia 10
PH - Filippine 10
VE - Venezuela 10
MX - Messico 9
AU - Australia 8
EG - Egitto 8
ID - Indonesia 8
SA - Arabia Saudita 8
UA - Ucraina 8
BO - Bolivia 6
PK - Pakistan 6
UZ - Uzbekistan 6
HU - Ungheria 5
JO - Giordania 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CR - Costa Rica 4
GR - Grecia 4
CL - Cile 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
IR - Iran 3
KR - Corea 3
MD - Moldavia 3
NP - Nepal 3
UY - Uruguay 3
CY - Cipro 2
HR - Croazia 2
JM - Giamaica 2
LB - Libano 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
AD - Andorra 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 5.429
Città #
Dallas 367
Dublin 273
Singapore 258
San Jose 224
Ashburn 198
Hong Kong 195
Beijing 168
Chandler 141
New York 90
Munich 74
Los Angeles 73
Ho Chi Minh City 66
Lauterbourg 66
Boardman 61
Hanoi 52
Helsinki 51
Nanjing 49
Milan 46
Shanghai 43
Moscow 41
Buffalo 32
Ann Arbor 27
Council Bluffs 27
Redondo Beach 27
Turku 27
Orem 26
Tokyo 26
Pavia 25
Lawrence 24
Princeton 24
Johannesburg 23
Jacksonville 22
Medford 22
Shenyang 22
São Paulo 21
Chennai 20
Frankfurt am Main 19
Naples 19
Changsha 18
Wilmington 18
Hebei 17
London 17
Nanchang 17
Da Nang 15
Linda a Velha 15
Warsaw 15
Nuremberg 14
Brussels 13
Rome 13
Santa Clara 13
Tampa 13
Brooklyn 12
Hangzhou 12
Jiaxing 12
Montreal 12
Poplar 12
The Dalles 12
West Jordan 12
Atlanta 10
Boston 10
Manchester 10
Pune 10
Seattle 10
Stockholm 10
Chicago 9
Denver 9
Toronto 9
Amsterdam 8
Biên Hòa 8
Casablanca 8
Falls Church 8
Tianjin 8
Buenos Aires 7
Monza 7
Phoenix 7
Quito 7
Rio de Janeiro 7
Düsseldorf 6
Falkenstein 6
Guayaquil 6
Haiphong 6
Hyderabad 6
Medellín 6
Norwalk 6
San Francisco 6
Tashkent 6
Washington 6
Amman 5
Baghdad 5
Cagliari 5
Cairo 5
Columbus 5
Mariglianella 5
Turin 5
Athens 4
Belo Horizonte 4
Cincinnati 4
Dhaka 4
Dong Ket 4
Guangzhou 4
Totale 3.532
Nome #
Remineralizing Treatments for Dental Erosion and Sensitivity in Patients Suffering from Gastroesophageal Reflux Disease (GERD): Randomized Clinical Trial 183
Study of the microbiota composition in adult celiac disease 181
STUDY OF THE CLINICAL AND MOLECULAR PHENOTYPE AND NATURAL HISTORY OF ENTEROPATHIES WITH VILLOUS ATROPHY OF UNKNOWN ORIGIN AND THERAPEUTIC POTENTIAL OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS 153
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. 144
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 143
Comparative Study of Salivary, Duodenal, and Fecal Microbiota Composition Across Adult Celiac Disease 116
Study of the microbiota composition in adult celiac disease 110
A second duodenal biopsy is necessary in the follow-up of adult coeliac patients. 104
−295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple’s disease 104
High Prevalence of Functional Gastrointestinal Disorders in Celiac Patients with Persistent Symptoms on a Gluten-Free Diet: A 20-Year Follow-Up Study 101
Is a detailed grading of villous atrophy necessary for the diagnosis of enteropathy? 99
Olmesartan-associated enteropathy: New insights on the natural history? Report of two cases 99
Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 97
The Relationship Between Child Mortality Rates and Prevalence of Celiac Disease 94
Clinical and gastro-duodenal histopathological features of enteropathy due to angiotensin II receptor blockers 94
Musculoskeletal Ultrasound to Identify Subclinical Joint and Periarticular Involvement in Patients With Inflammatory Bowel Disease: A Systematic Literature Review 94
New entity of adult ultra-short coeliac disease: the first international cohort and case–control study 92
Humoral immunogenicity of COVID-19 vaccines in patients with coeliac disease and other noncoeliac enteropathies compared to healthy controls 92
Pitfalls in the diagnosis of coeliac disease and gluten-related disorders 92
Low prevalence of upper endoscopic gastrointestinal findings despite high frequency of alarm symptoms at the time of diagnosis in adult coeliac disease 92
Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodies 91
Coeliac disease and obstetric and gynaecological disorders: Where are we now? 91
The GLU-10: a validated ten-point score to identify poorly instructed celiac patients in need of dietary interventions 88
Clinical phenotype and mortality in patients with idiopathic small bowel villous atrophy: a dual-centre international study 88
Optimising the follow-up of adult coeliac disease with a clinical-based score to identify patients in need of a histological reassessment: A retrospective single centre study 88
DQA1*0102 DQB1*0602 haplotype distinguishes coeliac disease and its complications from gluten unrelated enteropathies 87
Prevalence, incidence and clinical features of SARS-CoV-2 infection in adult coeliac patients 86
Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study 85
Comparison between SeHCAT test and clinical response to cholestyramine in patients with chronic diarrhea and high suspicion of bile acid malabsorption: A single-center prospective study 85
Flow cytometry for the assessment and monitoring of aberrant intraepithelial lymphocytes in non-responsive celiac disease and non-celiac enteropathies 83
Seronegative coeliac disease: clearing the diagnostic dilemma 81
Long-term morbidity and mortality in Whipple's disease: A single-center experience over 20 years 79
Fecal calprotectin measurement as a biomarker of severe disease phenotype in celiac disease and non-celiac enteropathies 78
Clinical and laboratory predictors and prevalence of immune reconstitution inflammatory syndrome in patients with Whipple's disease 78
Inadvertent and minimal gluten intake has a negligible role in the onset of symptoms in patients with coeliac disease on a gluten-free diet 78
Relationship between duodenal microbiota composition, clinical features at diagnosis, and persistent symptoms in adult Coeliac disease 76
Overview in the clinical management of patients with seronegative villous atrophy 75
Determinants and Trends of Adherence to a Gluten-Free Diet in Adult Celiac Patients on a Long-term Follow-up (2000–2020) 75
Prevalence of Whipple's disease in north-western Italy 73
Superior bowel preparation quality for colonoscopy with 1L-PEG compared to 2L-PEG and picosulphate: Data from a large real-world retrospective outpatient cohort 72
Is it time to rethink the burden of non-coeliac gluten sensitivity? A systematic review 72
A small bowel adenocarcinoma harboring a DDR2 mutation in a celiac patient 72
Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus 70
The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy 66
Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers 65
Enteropathies with villous atrophy but negative coeliac serology in adults: Current issues 64
Efficacy of a Low-FODMAP Diet for Coeliac Patients with Persistent IBS-like Symptoms despite a Gluten-Free Diet: A Systematic Review 63
Clinical outcomes of potential coeliac disease: a systematic review and meta-analysis 60
Patients with Whipple's disease have a high prevalence of Helicobacter pylori infection 58
Prevalence and clinical features of bile acid diarrhea in patients with chronic diarrhea 56
Long-Term Adherence to a Gluten-Free Diet and Quality of Life of Celiac Patients After Transition to an Adult Referral Center 54
Persistent villous atrophy predicts development of complications and mortality in adult patients with coeliac disease: a multicentre longitudinal cohort study and development of a score to identify high-risk patients 52
Prognosticating coeliac patients survival: the proconsul score. 50
Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature review 49
Risk of complications in coeliac patients depends on age at diagnosis and type of clinical presentation 48
Systematic review with meta-analysis: Cause-specific and all-cause mortality trends across different coeliac disease phenotypes 44
Biopsy‐Sparing Diagnosis of Coeliac Disease Based on Endomysial Antibody Testing and Clinical Risk Assessment 42
Seronegative villous atrophy 42
Applications of generative artificial intelligence in inflammatory bowel disease: A systematic review 41
A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient setting 41
HLA-DQ7.5 and coeliac disease 39
Resilience in Adult Coeliac Patients on a Gluten-Free Diet: A Cross-Sectional Multicentre Italian Study 38
Global prevalence of celiac disease in patients with Rome III and Rome IV irritable bowel syndrome: A systematic review and meta-analysis 34
Work Impairment in Patients with Celiac Disease and Its Relationship with Persistence of Symptoms, Dietary Adherence, Quality of Life, and Psychological Morbidity 34
Letter: The enigma of angiotensin receptor blocker-associated enteropathy—Authors' reply 34
Nonresponsive and complicated coeliac disease 34
Use of small-bowel capsule endoscopy in cases of equivocal celiac disease 33
Author's Reply: “Comment on gluten challenge study in adults on a gluten-free diet with unconfirmed coeliac disease” 31
Beyond gluten-free diet: a critical perspective on phase 2 trials on non-dietary pharmacological therapies for coeliac disease 30
Seronegative coeliac disease masquerading as irritable bowel syndrome type symptoms 30
Prevalence of gastroesophageal reflux disease in adult coeliac disease at diagnosis and during follow-up: a 20-year retrospective study 30
Diagnostic outcomes after gluten challenge in adult patients with unconfirmed coeliac disease already on a gluten‐free diet: A 20‐year retrospective cohort study 28
Reply 27
LONG-TERM PROGNOSIS of NON-CELIAC ENTEROPATHIES and A SCORE to IDENTIFY PATIENTS with POOR OUTCOMES: A 30-YEAR MULTICENTER LONGITUDINAL STUDY 27
The high prevalence of Whipple's disease in patients with inflammatory rheumatic diseases 25
Editorial: Endomysial Antibodies for a No-Biopsy Diagnosis of Coeliac Disease—The Jury Is Still out. Authors' Reply 22
null 20
Endoscopic techniques for the identification of duodenal villous atrophy in celiac disease: a systematic review and meta-analysis of diagnostic accuracy 19
Is it time to abandon night-before laxative bowel preparation for small-bowel capsule endoscopy? 15
Non-Coeliac Wheat Sensitivity: Symptoms in Search of a Mechanism, or a Distinct Well-Defined Clinical Entity? A Narrative Review 10
Totale 5.590
Categoria #
all - tutte 22.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.946


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 7 1 4
2021/2022127 2 0 2 2 6 11 4 13 7 8 14 58
2022/2023653 61 42 0 25 28 67 54 33 305 7 13 18
2023/2024490 52 67 9 24 21 99 33 15 2 100 33 35
2024/20251.150 49 79 30 28 21 110 52 57 277 47 148 252
2025/20262.857 207 179 427 403 385 102 457 157 365 175 0 0
Totale 5.590